“From knowing to knowing what to do, that is our path”
Dr. Capriati, Director of Corporate Clinical Research
Research follows a long path that starts with the need to cure patients and is developed through hypotheses and continuous verifications made in the context of clinical trials that generate a huge amount of recorded and processed data over the years.
Only in this way is it possible to guarantee a quality result, which in research means a sure result.
Development is rigorous.
Clinical trial criteria are rigorous.
The result is rigorous.
Phase 1 the molecule is tested to verify its safety and concentration in the body.
Phase 2 the initial data regarding effectiveness are collected and the correct dosage is established.
Phase 3 the therapeutic benefits are confirmed on a wider pool of patients. All collected data are checked by the authorities that approve the drug to be marketed.
Phase 4 we continue to monitor the drug that is administered to the world population. Anyone can report any undesirable effects. Menarini is always listening, all over the world, thanks to its pharmacovigilance team.
Florence - Pharmacology Department, Molecular Pharmacology Laboratory
Quantification of gene products by spectrophotometer